This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Drugmaker Auden Mckenzie’s bid to appeal cartel ruling refused by UK's top court

By Simon Zekaria ( February 6, 2025, 15:31 GMT | Insight) -- Drugmaker Auden Mckenzie’s bid to challenge a UK appeal court ruling over anticompetitive hydrocortisone drug supply has been rejected by the country’s highest court, according to a regulatory filing from Teva Pharmaceuticals. It relates to a Court of Appeal ruling last year that upheld the UK competition regulator’s cartel findings over a market-sharing agreement among drugmakers.Drugmaker Auden Mckenzie’s bid to challenge a UK appeal court ruling over anticompetitive hydrocortisone drug supply has been rejected by the country’s highest court, according to a regulatory filing from Teva Pharmaceuticals....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections